In which fields are tungsten alloy shielding components used, and what are their operational principles and performance outcomes?
The excellent shielding efficacy of tungsten alloy shielding containers against radioactive materials stems from the high density characteristics of tungsten alloys. Research has demonstrated that high metal density significantly enhances radiation shielding performance, with improved effectiveness correlating directly with increased density. Consequently, tungsten alloy shielding components exhibit superior shielding capabilities.
Among existing metals, lead and tungsten alloys possess relatively high densities. Although lead was introduced early in medical applications, prolonged use has revealed several issues: both lead itself and its compounds are toxic to human tissues. Poisoning occurs through inhalation of vapors or dust particles via respiratory pathways, subsequent transport by phagocytes to the bloodstream, or absorption through the digestive tract entering the circulatory system. Most poisoning cases involve exposure to lead or lead compounds; oral intake of 2–3 grams can cause toxicity, while 50 grams may be fatal. Relevant authorities are actively developing lead alternatives and gradually phasing out lead usage. Against this backdrop, tungsten has gained increasing prominence. High-density tungsten alloys are widely employed in shielding components due to their non-toxicity, safety profile, and abundant availability. Compared to lead, tungsten alloys demonstrate superior environmental benefits—they are non-toxic, do not produce radioactive substances, are easy to process, and have abundant reserves.
Tungsten alloy syringe shielding components are medical devices manufactured from tungsten alloys to protect patients during radioactive drug administration. These components utilize the exceptional shielding properties of highly dense tungsten alloys against radioactive particles. Tungsten alloys can achieve a density of 16.5–19.0 g/cm³, providing excellent shielding efficacy against radioactive particles. Tungsten alloy shielding components are widely used in medical applications as injection devices for isotope tracing to monitor drug efficacy. By leveraging the nuclear properties of radioactive isotopes that continuously emit characteristic radiation, nuclear detectors enable real-time tracking of their location, quantity, and transformation within or outside the body. Although stable isotopes do not emit radiation, their mass differences from conventional counterparts can be measured using mass spectrometers, gas chromatographs, nuclear magnetic resonance instruments, and other analytical devices. Exposure to radioactive substances can cause cellular damage and, in severe cases, pose life-threatening risks; tungsten alloy shielded needles thus protect individuals from such hazards during handling of radioactive materials.
These containers represent another category of tungsten alloy shielding components, specifically designed for storing radioactive medications in medical settings. Radioactive drugs are specialized pharmaceuticals containing radionuclides for diagnostic and therapeutic purposes—such as compounds or biological agents labeled with radionuclides like ³²P, ⁸⁹Sr, and ⁹⁰Y that emit pure beta radiation. Primarily used for shielding medical radioactive injections, pharmaceutical products, and radioactive sources emitting X-rays or gamma rays, these containers also serve applications in geological exploration involving radioactive materials.
Sintering is the primary manufacturing technique employed for tungsten alloy shielding components. Sintering is a heat treatment process used for green bodies or bulk powders, which typically exhibit low strength and density. To enhance their mechanical properties, these materials require thermal treatment under specific conditions: the green body or bulk powder is heated to temperatures below the melting point of its constituent elements (approximately 0.7–0.8 times the absolute melting point) and held at this temperature, promoting particle bonding and improving performance. Sintering plays a decisive role in determining the properties of tungsten alloy shielding components. The process induces interparticle bonding, significantly increases the strength of the sintered material, and generally elevates its density. During sintering, the green body undergoes a series of physicochemical changes: initial stages include evaporation/volatilization of moisture or organic compounds, removal of adsorbed gases, stress relief, and reduction of oxide layers on particle surfaces; followed by interatomic diffusion, adhesion flow, plastic flow, expansion of contact areas between particles, recrystallization, and grain growth.
